PO.TB04.04 · 肿瘤生物学
慢病毒载体诱导的小型猪脊髓低级别胶质瘤建模
Lentiviral vector induced modeling of low grade glioma in the minipig spinal cord
作者与单位 Authors & Affiliations
摘要 Abstract
中文摘要
胶质瘤代表了一个多样化的中枢神经系统肿瘤谱系,从侵袭性的高级别胶质瘤(HGG)到侵袭性较低的低级别胶质瘤(LGG)。我们团队此前使用PDGFB、HRAS和TP53在小型猪脊髓中建立了高级别胶质瘤模型。我们现在报道小型猪低级别胶质瘤模型的开发。使用表达PDGFB、BRAF V600E和TP53基因的慢病毒载体来构建低级别胶质瘤模型。通过行为学评估、用于病灶检测的MRI成像和组织病理学分析监测疾病进展。与此前表征的高级别表型不同,这些模型表现出独特的、侵袭性较低的低级别表型。两组均发展出具有不同组织学特征的脊髓病灶:第1组(PDGFB + shTP53)表现为具有均一肿瘤细胞、水肿和极少坏死的弥漫浸润性胶质瘤,而第2组(PDGFB + BRAF V600E + shTP53)表现出异质性病灶,结合了弥漫性胶质瘤成分和梭形细胞成分,伴有异型性增加、凋亡和更大范围的轴向累及。这些梭形细胞似乎起源于髓系而非胶质细胞谱系。这项工作建立了首个小型猪低级别胶质瘤模型,为研究低级别胶质瘤生物学以及开发针对脊髓肿瘤的新型治疗干预措施提供了一个临床相关的大型动物系统。
查看英文原文 English abstract
Gliomas represent a diverse spectrum of central nervous system tumors, ranging from aggressive high-grade gliomas (HGG) to less aggressive low-grade gliomas (LGG). Our group previously developed a high-grade glioma model in the minipig spinal cord using PDGFB, HRAS, and TP53. We now report the development of a minipig low-grade glioma model. Lentiviral vectors gene expression of PDGFB, BRAF V600E, and TP53 were used to generate the low-grade glioma model. Disease progression was monitored through behavioral assessment, MRI imaging for lesion detection, and histopathological analysis. Unlike the previously characterized high-grade phenotype, these models demonstrated a distinct, less aggressive low-grade phenotype. Both groups developed spinal cord lesions with divergent histological features: Group 1 (PDGFB + shTP53) displayed diffusely infiltrative gliomas with uniform tumor cells, edema, and minimal necrosis, while Group 2 (PDGFB + BRAF V600E + shTP53) exhibited heterogeneous lesions combining diffuse gliomatous and spindle cell components with increased atypia, apoptosis, and greater axial involvement. These spindle cells appear to originate from myeloid rather than glial lineage. This work establishes the first minipig low-grade glioma model, providing a clinically relevant large animal system for investigating low-grade glioma biology and developing novel therapeutic interventions for spinal cord tumors.
利益披露 Disclosure
K. Lei, None..
A. Mela, None..
T. Federici, None..
M. S. Tora, None..
M. Yonk, None..
Y. Lakhina, None..
B. Henshey, None..
M. Babbitt, None..
R. R. Khelo, None..
J. N. Bruce, None..
P. Canoll, None..
N. M. Boulis, None.